bioRxivMicrobiologyPreprint
Identification of 2-amino benzothiazoles with bactericidal activity against Mycobacterium tuberculosis
S. A. Bonnett, J.-A. Jee, S. Chettiar, Y. Ovechkina, A. Korkegian, E. Greve, J. Odingo, T. Parish
Abstract
We identified an amino-benzothiazole scaffold from a whole cell screen against recombinant Mycobacterium tuberculosis under expressing the essential signal peptidase LepB. The seed molecule had two-fold higher activity against the LepB hypomorph. Through a combination of purchase and chemical synthesis we explored the structure activity relationship for this series; 34 analogs were tested for anti-tubercular activity and for cytotoxicity against eukaryotic cells. We identified molecules with improved potency and reduced cytotoxicity. However, molecules did not appear to target LepB directly and did not inhibit protein secretion. Key compounds showed good permeability, low protein binding, and lack of CYP inhibition, but metabolic stability was poor with short half-lives. The seed molecule showed good bactericidal activity against both replicating and non-replicating bacteria, as well as potency against intracellular M. tuberculosis in murine macrophages. Overall, the microbiological properties of the series are attractive if metabolic stability can be improved, and identification of the target could assist in development of this series.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis
S. B. Singh, J. Odingo, … T. Parish·bioRxiv·Mar 10, 2018
- A competitive activity-based protein profiling platform yields cell wall synthesis inhibitors active against replicating and non-replicating Mycobacterium tuberculosis
M. Li, H. V. Patel, … J. C. Seeliger·bioRxiv·Apr 16, 2021
- Azetidines kill Mycobacterium tuberculosis without detectable resistance by blocking mycolate assembly.
A. B. Lanne, Y. Cui, … L. J. Alderwick·bioRxiv·Sep 3, 2020
- Identification of novel chemical scaffolds that inhibit the growth of Mycobacterium tuberculosis in macrophages
S. Ahmed, A. J. Manning, … T. Parish·bioRxiv·Sep 28, 2021
- Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting Mycobacterium tuberculosis
S. Roy, T. Berida, … C. L. Stallings·bioRxiv·Nov 14, 2022
- Low-cost drug discovery with engineered E. coli reveals an anti-mycobacterial activity of benazepril
Nadine Bongaerts, Zainab Edoo, … Edwin H. Wintermute·bioRxiv·Mar 26, 2021